Marsha Linehan, PhD is the developer of Dialectical Behavior Therapy. DBT is internationally recognized as the most effective treatment for Borderline Personality Disorder and chronic self-harming and suicidal behaviors. DBT has revolutionized the treatment of BPD, providing a structured, evidenc...

Peter Fonagy, PhD is the co-developer of Mentalization Based Treatment for Borderline Personality Disorder. Mentalization Based Treatment is rooted in attachment theory and the primary goals of treatment are to improve mentalization skills, learn how to work with current emotions and establish r...

Alan Fruzzetti, PhD is an internationally recognized Dialectical Behavior Therapy researcher, teacher, and supervisor. His research focuses on the connections between severe individual problems (including suicidality and non-suicidal self-harm) and interpersonal/family processes, and their inter...

Antonia New, MD is one of the foremost investigators studying the neurobiology of Borderline Personality Disorder. Her research focus is on emotion dysregulation in borderline personality disorder, which underlies some of the interpersonal difficulties encountered in this disorder. Her work exami...

Alec Miller, PsyD specializes in the treatment of adolescents for borderline personality disorder, depression, stress, suicide and self-injury. He has researched and adapted the use of Dialectical Behavior Therapy for suicidal, multi-problem adolescents and has disseminated the use of evidence-ba...

Perry Hoffman, PhD was a dedicated clinician who fought for the rights people with Borderline Personality Diosrder and against the stigma so often directed towards their families. Recognizing the suffering of people with BPD and their families. Dr. Hoffman's work touched the lives of thousand of ...

Blaise Aguirre, MD is internationally recognized for his extensive work in the treatment of mood and personality disorders in adolescents. He is an expert in child, adolescent, and adult psychotherapy, including dialectical behavior therapy, Dr. Aguirre is the founding medical director of McLean ...

Jon G. Allen, PhD is a prominent clinical psychologist known for his expertise in trauma, psychotherapy, and attachment theory. He emphasizes the central role of mentalizing in building effective therapeutic relationships, particularly for individuals struggling with attachment-related trauma.

M...

Paula Tusiani-Eng, LMSW, is the Founder and Executive Director of Emotions Matter, Inc., a non-profit organization created by a network of individuals over the age of 18 and their families. Emotions Matter is dedicated to improving social connection, awareness and health care systems for those i...

Mary Zanarini’s landmark, decades-long study of Borderline Personality Disorder, The McLean Study of Adult Development, significantly changed our understanding of BPD. Her study revealed that BPD has the best symptomatic outcome of all major psychiatric illnesses, is highly treatable, has a high ...

John Gunderson, MD, is often referred to as "The Father of BPD”. As a professor of psychiatry at Harvard Medical School and McLean Hospital, he was a pioneer in the diagnosis, treatment, and research of Borderline Personality Disorder. He discovered that many patients were being misdiagnosed as ...

Barbara Stanley, PhD received international recognition for the development of a deceptively simple and effective tool for suicide prevention. The Stanley-Brown Safety Planning Intervention, which she co-developed with Gregory K. Brown, PhD, asks patients who are dealing with suicidal urges to wr...

Larry Siever, MD received the International Society for the Study of Personality Disorder’s senior investigator award “in recognition of distinguished and pioneering contributions to the study of personality disorders”. Dr. Siever’s work provided the scaffolding for a new way of thinking about pe...

Harriet Lefley, PhD, was a highly distinguished pioneer in the fields of cross-cultural mental health care and advocacy for the mentally ill. As Professor with the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine, Dr. Lefley was Principle or Co...

Wayne Fenton, MD was a director at the National Institute of Mental Health. He played a pivotal role in shaping effective clinical trials for mental illness. His understanding of what mattered in the real world informed NIMH research programs fostered initiatives that promoted practical and effec...

Carlos Buesa, PhD is the founder of Oryzon Genomics and has served as Chief Executive Officer since then. Oryzon is a biopharmaceutical company that is considered a European leader in epigenetics. Oryzon is currently conducting Phase III clinical trial evaluating their epigenetic compound vafidem...